Snipd home pageGet the app
RiskReversal Pod chevron_right

Okay, Computer: Ro CEO Zach Reitano on Weight Loss Drugs

Jul 12, 2023
34:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
1
Introduction
00:00 • 2min
chevron_right
2
The Power of a Doctor
01:59 • 3min
chevron_right
3
The Impact of OBC on Health Care
05:23 • 4min
chevron_right
4
The Importance of Onboarding for Health Insurance
09:46 • 3min
chevron_right
5
The Importance of Taking Medication for Diabetes
12:55 • 1min
chevron_right
6
Novo Nordisk's Row Body Program Is in Short Supply
14:23 • 4min
chevron_right
7
The Cardiometabolic Revolution
18:28 • 3min
chevron_right
8
Current: A FinTech Company Disrupting Traditional Banking
21:43 • 2min
chevron_right
9
The Price of Obesity Drugs
23:15 • 3min
chevron_right
10
The Importance of Oral Drugs
25:56 • 3min
chevron_right
11
The Impact of Our Program on My Dad's Life
29:22 • 2min
chevron_right
12
Row of You Need Data to Move a Brain
31:15 • 4min
chevron_right

Dan Nathan is joined by Ro CEO Zach Reitano to discuss GLP-1 weight loss medications like Wegovy or Ozempic, and why the company started offering it to patients. 


—

Learn more about Ro Body at ro.co/okay

----

Email us at contact@riskreversal.com with any feedback, suggestions, or questions for us to answer on the pod and follow us @OkayComputerPod, or @riskreversalmedia on Threads.

Follow us on Instagram @RiskReversalMedia

Subscribe to our YouTube page

HomeTop podcastsPopular guestsTop books